These authors contributed equally to this study. Lipopolysaccharides (LPSs) and glycosaminoglycans (GAGs) are polymeric structures containing negatively charged disaccharide units that bind to specialized proteins and peptides in the human body and control fundamental processes such as inflammation and coagulation. Surprisingly, some proteins can bind both LPSs and GAGs with high affinity, suggesting that a cross-communication between these two pathways can occur. Here, we explore whether GAGs and LPSs can share common binding sites in proteins and what are the structural determinants of this binding. We found that the LPS-binding peptide YI12WF, derived from protein FhuA, can bind both heparin and E. coli LPS with high affinity. Most interestingly, mutations decreasing heparin binding in the peptide also reduce LPS affinity. We show that such mutations involve the CPC clip motif in the peptide, a small three-dimensional signature required for heparin binding. Overall, we conclude that negatively charged polysaccharide-containing polymers such as GAGs and LPSs can compete for similar binding sites in proteins, and that the CPC clip motif is essential to bind both ligands. Our results provide a structural framework to explain why these polymers can cross-interact with the same proteins and peptides and thus contribute to the regulation of apparently unrelated processes in the body.
Introduction
Glycosaminoglycans (GAGs) are long, unbranched polysaccharides made up from repeating disaccharide units, commonly containing an amino sugar (N-acetylglucosamine or N-acetylgalactosamine) bound to a uronic sugar (glucuronic acid or iduronic acid) or galactose [1] . Specifically, the heparin repeating unit consists of a 2-O-sulfo-a-L-iduronic acid molecule bound to an a-D-N-sulfoglucosamine-6-O-sulfate through a b-1,4 bond (electronic supplementary material, figure S1A). On the other hand, lipopolysaccharides (LPSs) are glycosylated lipids made up of a lipid A molecule covalently bound to a polysaccharide moiety of variable composition [2, 3] . In its turn, the lipid A backbone consists of a b-glucosamine molecule bound to b-glucosamine-1-phosphate by a b-1,6 linkage (electronic supplementary material, figure S1A). Though these molecules are compositionally different, they both contain negatively charged disaccharide units that can be potentially bound by positively charged protein-binding pockets. Whether these two substrates are orthogonal or can compete for similar binding sites is currently unknown.
Recently, the binding of human LPS-binding protein (hLBP) to heparin through its LPS-binding site was reported to contribute to the regulation of the inflammatory response [4] . Also, the camel short peptidoglycan recognition protein (S-PGRP), a pattern-recognition and effector molecule in innate immunity, is able to bind heparin using its LPS-binding site [5] . The human eosinophil cationic protein (ECP) is another protein involved in host immunity with an unusual high binding affinity to both GAGs and LPSs [6] [7] [8] [9] . Conversely, in bacteria, some LPS-embedded outer membrane proteins can bind GAGs, including heparin [10] , promoting cell adherence and infection [11] . Hence, it is reasonable to suggest that hLBPs may also bind GAGs and vice versa and can cross-regulate important functions in a biological context.
Among bacterial hLBPs, FhuA is a multifunctional outer membrane protein in E. coli that actively transports siderophores such as ferrichrome and is essential for iron metabolism [12] . Interestingly, it also mediates transport of several antibiotics such as albomycin [13] and rifamycin [14] . FhuA is able to bind glucosamine phosphate groups in LPSs [15] , suggesting that it could also bind GAGs. Though FhuA is a 79 kDa protein, its LPS-binding site can be reproduced by a short peptide (YI12WF) that retains most of the LPS-binding affinity of the original protein [16, 17] . YI12WF is composed of two hydrophobic regions separated by a cluster of Lys and Arg that adopts a horseshoe structure in the presence of LPSs, held together by p -p stacking interactions between Tyr 1 and Phe 11 [16] . Positively charged residues in the peptide would bind the phosphate and carboxylate groups of lipid A disaccharide, whereas hydrophobic residues would direct the peptide to the lipid core [16] . Though GAGs lack a lipophilic core, the interaction would still be driven by electrostatic interactions between Lys and Arg in proteins with negatively charged groups in the polymer.
We recently described a 'CPC clip motif', containing two cationic (C and C') and one polar residue (P), as the minimum structural signature required for heparin binding [18] . The motif was found in all proteins reported to bind heparin at the time [18] , and later studies have also found CPC motifs in newly characterized proteins [19, 20] . Given the similarity between GAGs like heparin and the disaccharide unit of LPSs, we reasoned that a CPC clip motif might also be a structural feature present and required for LPS binding.
In this work, we show that FhuA-derived peptide YI12WF can bind both LPS and heparin with high affinity, with binding dependent on the CPC clip motif. Our results shed light on the structural determinants for heparin binding and provide a structural framework to understand binding promiscuity. More research is required to determine whether this crossbinding could have major biological implications in the regulation of pathways involved in GAG-and LPS-binding, such as coagulation and inflammation [21 -23] .
Results and discussion
As detailed before, some proteins (i.e. hLBP and FhuA) can bind to both GAGs and LPSs. In both cases, one can define a CPC motif, directly involved in LPS binding (electronic supplementary material, figure S1B,C), where protein cationic residues (Arg or Lys) establish one or more salt bridges with phosphate groups in LPSs while a polar group (Gln) forms a hydrogen bond with a polar group in the hexose. In all cases examined, the distances between cationic and polar residues are consistent with the CPC geometry [18] . Hence, we hypothesized that a CPC motif could be structurally relevant to explain binding promiscuity in hLBPs. To test our hypothesis, we synthesized the YI12WF peptide [16, 17] (table 1) , which reproduces the binding site of protein FhuA (electronic supplementary material, figure S1C), and tested whether this peptide could also bind heparin.
We measured the binding of peptide YI12WF to heparin by isothermal titration calorimetry (ITC) and found a low free energy value (DG 0 ¼ 210.2 kcal mol
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, figure 1a and table 2), consistent with a strong interaction between the peptide and the ligand. In all cases, the number of molecules in the stoichiometry of the reaction (N) was 1. We observed the enthalpy (27.10 kcal mol
) to be larger than the entropy contribution (3.1 kcal mol 21 ), suggesting that electrostatic and hydrogen-bond contacts between the negatively charged sulfate groups in heparin and positively charged residues (Arg and Lys) in the peptide dominate the interaction (table 2) . Accordingly, a CPC clip motif formed by residues Tyr 1, Lys 5 and Arg 8 (figure 1b) could be defined for YI12WF. The distances between the centres of mass for these residues are in agreement with those observed for a CPC motif (figure 1c).
To rule out possible unspecific binding between YI12WF and heparin, we synthesized four variants, called YI12WF5Q, YI12WF6Q, YI12WF7Q and YI12WF8Q (table 1) , that correspond to the mutation of the four central cationic residues to Gln. We also synthesized FI12WF (table 1) to explore the role of the polar residue, Tyr 1. If Lys 5 and Arg 8 were essential for the interaction, as expected in a CPC motif, any mutation in these residues would result in poorer binding (higher K d ). Instead, if the interaction was unspecific, a similar contribution should be expected for all mutated residues.
Consistently with our CPC model, peptides YI12WF5Q and YI12WF8Q displayed a strong, fivefold to 14-fold increase in K d over the original peptide YI12WF. It is worth noting that these changes in K d are mainly due to a decrease in the TDS 0 term (table 2), suggesting that configurational entropy of the peptide-ligand ensemble affects the binding. By contrast, K d values for mutants YI12WF6Q and YI12WF7Q were comparable (less than twofold increase) to the parent peptide. Interestingly, peptide FI12WF, where the polar residue in the CPC motif is disrupted, showed a sharp decrease in heparin binding, probably for similar reasons to those of YI12WF5Q and YI12WF8Q peptides.
We also wondered whether mutants with reduced affinity for heparin would decrease the affinity for LPSs. To this end, we performed titration assays for all peptides using fluorescently labelled cadaverine. Cadaverine binds to the lipid A moiety of the LPS, resulting in fluorescence quenching. After the peptide is added, it competes and dislodges cadaverine, increasing the fluorescence signal. Using this assay, both total cadaverine displacement and IC 50 can be quantified.
Peptide YI12WF could virtually displace all molecules of cadaverine, with an IC 50 of 60 nM (table 2), in tune with the affinity (K d ) values observed for heparin (table 2) . These results confirm that YI12WF is a strong LPS-binding peptide, in agreement with LPS-neutralizing activities observed before [17] . Peptides YI12WF5Q and YI12WF8Q showed a marked decrease in cadaverine displacement along with a rise in IC 50 , again suggesting that both cationic residues are required rsif.royalsocietypublishing.org J. R. Soc. Interface 14: 20170423 for the peptide to strongly bind to the phosphate groups in LPSs. On the other hand, peptides YI12WF6Q and YI12WF7Q showed minor changes in cadaverine displacement and slightly increased IC 50 values, probably due to lower charge density. Finally, while peptide FI12WF, with the polar Tyr residue replaced by Phe, did not show a significant reduction in displacement, it underwent a sharp drop in binding affinity (IC 50 greater than twofold higher). These results seem to suggest that Tyr is important for the correct positioning of the peptide when interacting with LPSs.
Overall, our results indicate that peptide binding to both heparin and LPS is fundamentally drawn by electrostatic interaction between the negatively charged groups of the polymer and the positively charged residues in the peptide. The results also confirm that a CPC clip motif is required for peptide binding to both heparin and LPS. Hence, deletion The distances are measured for the centre of mass of the three residues involved in the motif (data obtained from [18] ). The distances for peptide YI12WF are displayed as asterisks in the plot. ] o are the theoretical and observed molecular weights in Da, respectively, and pI is the peptide isoelectric point based on amino acid composition [24] . Hydrophobicity was calculated using the gravy index score [25] .
rsif.royalsocietypublishing.org J. R. Soc. Interface 14: 20170423 or substitution of residues that eliminate the CPC motif promotes a decrease in the binding affinity. Remarkably, in mutations involving the CPC motif, we observed a relevant change in the entropic contribution to binding that may result from (i) the contact region between peptide and ligand affecting the mobility of heparin and hence the number of possible conformations, and/or (ii) the exposure of hydrophobic residues in the peptide enhancing water ordering, hence decreasing its associated entropy.
One way to explain such results would be that the three CPC residues undergird the peptide horseshoe structure, while mutations targeting the motif destabilize it and affect binding. Though this might be the case for Tyr 1, which stacks with Phe 11 closing the horseshoe structure, it is less obvious for the cationic residues, which are fully exposed. To further clarify this point, we performed molecular dynamics (MD) simulations of peptide mutants in the presence of heparin and analysed the conservation of the horseshoe morphology (figure 2; electronic supplementary material, figure S2 ). We indeed found no direct correlation between peptide structure and heparin-binding affinity, concluding that differences in binding must be due to other structural considerations.
Another explanation would be that, despite changes in peptide conformation, the overall structure of the CPC motif is conserved, hence imposing less constraints. The CPC motif contains two cationic (C and C') and one polar residue (P) separated by a defined distance (figure 1b,c) [18] . To ascertain this, we analysed the conservation of the CPC motif in our models obtained by MD simulations. We observed that deletion of Lys 5 disrupts the CPC motif ( peptide YI12WF5Q, figure 2 ) and, as a result, the peptide loses a fundamental salt bridge between Lys 5 and the corresponding sulfate group in heparin. Also, mutation of Arg 8 for Gln abolishes the CPC motif and forces the peptide to adopt a more linear conformation (peptide YI12WF8Q, figure 2 ; electronic supplementary material, figure S2) . In both cases, we observed a significant increase in surface exposure of the hydrophobic residues in the peptide (electronic supplementary material, figure S3 ). Exposure of hydrophobic residues forces water to form ordered cages around them, leading to a decrease in entropy, as observed for these peptides (table 2) .
By contrast, removal of Arg 6 does not disrupt the CPC motif and all residues can still interact with heparin ( peptide YI12WF6Q, figure 2 ). On its turn, deletion of Lys 7 abolishes the original CPC motif geometry but can create another one replacing Tyr 1 by Gln 7 ( peptide YI12WF7Q, figure 2) though it is geometrically constrained because the distances between PC' and CC' are too small. This rearrangement, though retaining a good geometry, may be responsible for the slight increase in K d observed experimentally.
Last but not least, replacement of Tyr 1 by Phe rules out the possibility of a CPC motif, as no polar residue is left to substitute for Tyr 1 ( peptide FI12WF, figure 2) in assisting the interaction with hexose polar residues and configuring a suitable geometry. Hence, we can conclude that the CPC motif provides an appropriate spatial arrangement of charge that allows strong binding to negatively charged units in heparin and LPSs. In the absence of a well-defined CPC motif the peptide is not able to adopt a suitable conformation, thus lowering the affinity for the ligand.
In summary, our results suggest that LPSs and heparin can bind similar regions in proteins, provided they contain a CPC clip motif as required minimal structure. In a more biological context, these results may help understand why this cross-binding is also observed for other hLBPs. For example, Heinzelmann & Bosshart [4] recently showed that heparin can bind to hLBP and, most importantly, enhance the proinflammatory responses to LPS of blood monocytes. Indeed, the crystal structure of hLBP bound to N-acetyl-D-glucosamine shows a putative CPC clip motif that could potentially bind heparin (electronic supplementary material, figure S1B). Such observations may prove generalizable to other LPS-binding proteins and may represent a biological interplay between LPS and heparin that links inflammatory conditions with coagulation. Whether the reverse-i.e. heparin-binding proteins playing a role in LPS binding-is also true is currently unknown but should merit further exploration in the future. Also, it is worth investigating whether other GAGs (e.g. heparan sulfate) show similar binding affinities and whether this may have implications in other biological functions such as cell adhesion and infection.
Material and methods

Materials
BODIPY
w TR cadaverine was purchased from Invitrogen (Carlsbad, CA, USA). LPS, purified by phenol extraction, and low-molecular-weight (6000 Da average) heparin sodium salt from porcine intestinal mucosa were purchased from Sigma-Aldrich (St Louis, MO, USA). Peptides were prepared by solid-phase synthesis as described in the electronic supplementary material.
Isothermal calorimetry
High-sensitivity ITC was performed on a VP-ITC (GE Healthcare, Uppsala, Sweden). ITC was performed of each peptide incubated with heparin at 258C in 5 mM Hepes ( pH 7.2) with 100 mM NaCl. Peptide stock was prepared at 300 mM. Heparin (10 mM) in the calorimetric cell was titrated every 4 min with 2.5 ml peptide solution, and heat exchanges were measured. Concentrations are defined per molecule. Control titrations for dilution heat resulted in a negligible endothermic reaction as a result of dilution. The resulting data were integrated with MicroCal Origin 7.0 using the one-set-of-sites binding model to elucidate the equilibrium association constant (K a ) and the enthalpy change (DH 0 ). The entropy change DS 0 was calculated from the fundamental thermodynamic equations: DG 0 ¼ 2RT * ln K a and TDS 0 ¼ (DH 0 2 DG 0 ).
Lipopolysaccharide binding assay
LPS binding was assessed using the fluorescent probe BC as described previously [23] . Peptide stock was prepared at 100 mM. Briefly, the displacement assay was performed by adding 1 -2 ml aliquots of peptide to 1 ml of a continuously stirred mixture of LPS (10 mg ml
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) and BC (10 mM) in 10 mM phosphate buffer and 100 mM NaCl ( pH 7.5). Fluorescence measurements were performed on a Cary Eclipse spectrofluorimeter, with 580 nm and 620 nm as BC excitation and emission wavelengths, respectively. The excitation slit was set at 2.5 nm, and the emission slit was set at 20 nm. Final values correspond to an average of four replicates and were the mean of a 0.3 s continuous measurement. ED 50 values were computed at the midpoint of the fluorescent signal against the protein concentration of the displacement curve by a curve-fitting of the data to the equation:
where OF is the occupancy factor, F 0 is the fluorescence intensity of BC alone, F bound is the intensity in the presence of LPS at the saturation concentration and F is the intensities of the LPS/BC mixtures at each peptide concentration [23] .
Molecular dynamics simulations
All MD simulations with or without octameric heparin were conducted using the GROMACS 4.6.7 package [26] . The force fields ffamber99SB [27 -29] and GLYCAM06j-1 [30] were employed as the parameters for protein and ligand heparin, respectively. Initial structures were solvated in a cubic box of TIP3P water with a minimum distance of 1.0 nm between protein and the faces of the box. Na þ and Cl 2 ions were added to neutralize the system at an ionic strength of 0.15 M. Electrostatic interactions were calculated using the particle mesh Ewald method under periodic boundary conditions. Structures were energy-minimized and equilibrated by molecular dynamics for 5 ns.
Production simulations were run on a GPU (GeForce GTX 970) and 12 CPUs for 100 ns with a time step of 2 fs. NPT conditions were stabilized at 300 K by a V-rescale thermostat [31] , and at 1 atm by a Parinello -Rahman barostat [32] . Bonds were rsif.royalsocietypublishing.org J. R. Soc. Interface 14: 20170423 constrained using the LINCS algorithm. Representative structures for different analyses were extracted from trajectories with g_cluster based on mutual RMSDs; the structures chosen were close to the cluster centres of the trajectories. For all statistical data analyses, we used R v. 3.3.3. Heparin ligands were prepared as described in the electronic supplementary material.
Data accessibility. The data that support the findings of this study are available from the corresponding authors upon reasonable request.
